Tagrisso™ 80mg
Brand Name: Tagrisso™ 80mg
Composition:Each film-coated tablet contains Osimertinib Mesylate 95.4mg (Equivalent to Osimertinib 80mg).
Brand Name: Tagrisso™ 80mg
Product Description
Medical Info
Tagrisso™ 80mg (Osimertinib) is a targeted prescription medication classified as a third-generation kinase inhibitor. It is primarily indicated for treating adult patients with non-small cell lung cancer (NSCLC) whose tumors present specific epidermal growth factor receptor (EGFR) mutations. This advanced therapeutic option works by blocking abnormal signaling pathways that drive cancer cell proliferation, effectively suppressing tumor growth. Taken once daily as a film-coated oral tablet, it can be administered alone or combined with select chemotherapy regimens. Proper oncology supervision and molecular diagnostic testing are essential before initiating therapy.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
